Showing 1 - 4 results of 4 for search 'Ryosuke Hirohata', query time: 0.02s
Refine Results
-
1
-
2
-
3
Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma by Manato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada
Published 2023-04-01
Article -
4